AbbVie Inc. — Director's Dealing 2025

Mar 4, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AbbVie Inc. (ABBV)
CIK: 0001551152
Period of Report: 2025-02-28

Reporting Person: SALEKI-GERHARDT AZITA (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-02-28	Common Stock, $0.01 par value	F	17056	$205.02	Disposed	177292	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock, $0.01 par value	2601	Indirect
Common Stock, $0.01 par value	3873	Indirect

Footnotes

F1: Balance in AbbVie Savings program as of January 31, 2025. Balance includes shares acquired pursuant to a dividend reinvestment feature.

F2: The reporting person disclaims beneficial ownership of all securities held by her spouse.